Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Equity (2021 - 2025)

Historic Return on Equity for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to 4.85%.

  • Biofrontera's Return on Equity rose 64100.0% to 4.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.85%, marking a year-over-year increase of 64100.0%. This contributed to the annual value of 3.85% for FY2024, which is 24500.0% down from last year.
  • As of Q3 2025, Biofrontera's Return on Equity stood at 4.85%, which was up 64100.0% from 7.96% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Return on Equity ranged from a high of 74.13% in Q1 2024 and a low of 6.9% during Q4 2023
  • For the 5-year period, Biofrontera's Return on Equity averaged around 5.21%, with its median value being 1.08% (2023).
  • Per our database at Business Quant, Biofrontera's Return on Equity skyrocketed by 748000bps in 2024 and then crashed by -788000bps in 2025.
  • Biofrontera's Return on Equity (Quarter) stood at 12.48% in 2021, then plummeted by -100bps to 0.03% in 2022, then crashed by -24969bps to 6.9% in 2023, then soared by 48bps to 3.56% in 2024, then soared by 236bps to 4.85% in 2025.
  • Its Return on Equity stands at 4.85% for Q3 2025, versus 7.96% for Q2 2025 and 4.67% for Q1 2025.